Linezolid Accord

Linezolid, the active ingredient in Linezolid Accord, is an oxazolidinone presented as an intravenous formulation for IV use. It treats skin and soft tissue infections and both community‑acquired and nosocomial pneumonia caused by susceptible Gram‑positive bacteria in adult patients. GNH USA supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is indicated for infections caused by susceptible Gram‑positive bacteria, particularly in the skin, soft tissues, and respiratory tract. - Skin and soft tissue infections: effective against susceptible Gram‑positive organisms, reducing infection severity. - Community‑acquired pneumonia: treats infections caused by susceptible Gram‑positive bacteria. - Nosocomial pneumonia: used for hospital‑acquired pneumonia due to susceptible Gram‑positive pathogens.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring during therapy. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Anemia: reduction in red blood cell levels. - Peripheral neuropathy: nerve damage presenting as tingling or numbness. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Optic neuritis: inflammation of the optic nerve affecting vision. - Lactic acidosis: rare metabolic disturbance with high morbidity.

Before initiating therapy, clinicians should consider several safety measures. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes and observe for hepatotoxicity. - Hematologic monitoring: perform regular complete blood counts to detect cytopenias. - Serotonergic agents: avoid concomitant use due to risk of serotonin syndrome. - Pregnancy: safety unknown; use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension and serotonin syndrome. - Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants): may precipitate serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, necessitating coagulation monitoring. - Antacids containing magnesium or aluminum: can affect absorption, consider timing adjustments. - Ethanol: potential disulfiram‑like reaction, advise patient to limit alcohol intake.